Page last updated: 2024-08-24

depsidone and Leukemia, Promyelocytic, Acute

depsidone has been researched along with Leukemia, Promyelocytic, Acute in 2 studies

*Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Adfa, M; Avidlyandi, A; Koketsu, M; Ninomiya, M; Sanjaya, A1
Furukawa, H1

Reviews

1 review(s) available for depsidone and Leukemia, Promyelocytic, Acute

ArticleYear
[Search of novel bioactive natural products from plant sources--novel structures and biological activities--].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2009, Volume: 129, Issue:10

    Topics: Acridones; Alkaloids; Animals; Antineoplastic Agents; Coumarins; Depsides; Drug Discovery; HL-60 Cells; Humans; Lactones; Leukemia, Promyelocytic, Acute; Mice; Nitric Oxide; Rutaceae; Skin Neoplasms; Xanthones

2009

Other Studies

1 other study(ies) available for depsidone and Leukemia, Promyelocytic, Acute

ArticleYear
A New Depsidone from Teloschistes flavicans and the Antileukemic Activity.
    Journal of oleo science, 2020, Dec-01, Volume: 69, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Ascomycota; Cell Proliferation; Depsides; Emodin; HL-60 Cells; Humans; Lactones; Leukemia, Promyelocytic, Acute

2020